
Cipla Limited has informed the Exchange regarding a press release dated November 17, 2021, titled "Cipla launches Spirofy��: Strengthens its lung leadership position by facilitating early diagnosis for COPD".
Filed with NSE · · 3 pages · English
This innovative device aims to enhance early diagnosis of COPD, which is a significant health issue in India, by providing accurate results and ease of use for physicians. The launch is part of Cipla's broader campaign to raise awareness about respiratory diseases and improve patient outcomes through better diagnostic tools.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Cipla Limited has informed the Exchange regarding a press release dated November 17, 2021, titled "Cipla launches Spirofy��: Strengthens its lung leadership position by facilitating early diagnosis for COPD".
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla